Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization?

Kaplan A, Arsenault P, Aw B, Brown V, Fox G, Grossman R, Jadavji T, Laferrière C, Levitz S, Loeb M, McIvor A, Mody CH, Poulin Y, Shapiro M, Tessier D, Théorêt F, Weiss K, Yaremko J, Zhanel G.

Can Fam Physician. 2019 Sep;65(9):625-633. Review.

2.

Corrigendum to "Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada".

Thanh NX, Jacobs P, Suggett J, McIvor A, Kaplan A.

Can Respir J. 2019 May 19;2019:5906984. doi: 10.1155/2019/5906984. eCollection 2019.

3.

Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada.

Thanh NX, Jacobs P, Suggett J, McIvor A, Kaplan A.

Can Respir J. 2019 Jan 10;2019:9176504. doi: 10.1155/2019/9176504. eCollection 2019. Erratum in: Can Respir J. 2019 May 19;2019:5906984.

4.

Real-life effectiveness of indacaterol-glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study.

Kaplan A, Chapman KR, Anees SM, Mayers I, Rochdi D, Djandji M, Préfontaine D, McIvor A.

Int J Chron Obstruct Pulmon Dis. 2019 Jan 18;14:249-260. doi: 10.2147/COPD.S185485. eCollection 2019.

5.

Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials.

Martinez FJ, Rabe KF, Calverley PMA, Fabbri LM, Sethi S, Pizzichini E, McIvor A, Anzueto A, Alagappan VKT, Siddiqui S, Reisner C, Zetterstrand S, Román J, Purkayastha D, Bagul N, Rennard SI.

Am J Respir Crit Care Med. 2018 Nov 15;198(10):1268-1278. doi: 10.1164/rccm.201712-2493OC.

PMID:
29763572
6.

'Bottom dog men': Disability, Social Welfare and Advocacy in the Scottish Coalfields in the Interwar Years, 1918-1939.

Turner A, McIvor A.

Scott Hist Rev. 2017 Oct;96(2):187-213. doi: 10.3366/shr.2017.0335.

7.

GOLD Stage and Treatment in COPD: A 500 Patient Point Prevalence Study.

Safka KA, Wald J, Wang H, McIvor L, McIvor A.

Chronic Obstr Pulm Dis. 2016 Dec 22;4(1):45-55. doi: 10.15326/jcopdf.4.1.2016.0126.

8.

Relapse, re-infection and mixed infections in tuberculosis disease.

McIvor A, Koornhof H, Kana BD.

Pathog Dis. 2017 Apr 1;75(3). doi: 10.1093/femspd/ftx020. Review.

PMID:
28334088
9.

Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial.

Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Anzueto A, Alagappan VK, Siddiqui S, Rekeda L, Miller CJ, Zetterstrand S, Reisner C, Rennard SI.

Am J Respir Crit Care Med. 2016 Sep 1;194(5):559-67. doi: 10.1164/rccm.201607-1349OC.

PMID:
27585384
10.

Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.

Rennard SI, Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Siddiqui S, Anzueto A, Zhu H.

Int J Chron Obstruct Pulmon Dis. 2016 Aug 17;11:1921-8. doi: 10.2147/COPD.S109661. eCollection 2016.

11.

A randomized controlled trial of an early-intervention, computer-based literacy program to boost phonological skills in 4- to 6-year-old children.

O'Callaghan P, McIvor A, McVeigh C, Rushe T.

Br J Educ Psychol. 2016 Dec;86(4):546-558. doi: 10.1111/bjep.12122. Epub 2016 Jul 30.

PMID:
27473924
12.

The effects of elevated CO2 and eutrophication on surface elevation gain in a European salt marsh.

Reef R, Spencer T, Mӧller I, Lovelock CE, Christie EK, McIvor AL, Evans BR, Tempest JA.

Glob Chang Biol. 2017 Feb;23(2):881-890. doi: 10.1111/gcb.13396. Epub 2016 Jul 9.

PMID:
27310520
13.
14.

The COPD Foundation Pocket Consultant Guide.

Thomashow B, Crapo J, Yawn B, McIvor A, Cerreta S, Walsh J, Mannino D, Rennard S.

Chronic Obstr Pulm Dis. 2014 May 6;1(1):83-87. doi: 10.15326/jcopdf.1.1.2014.0124. Review.

15.

Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, recommendations of the COPD Foundation.

Rennard S, Thomashow B, Crapo J, Yawn B, McIvor A, Cerreta S, Walsh J, Mannino D.

COPD. 2013 Jun;10(3):378-89. doi: 10.3109/15412555.2013.801309.

PMID:
23713598
16.

Update on exhaled nitric oxide in pulmonary disease.

Spitale N, Popat N, McIvor A.

Expert Rev Respir Med. 2012 Feb;6(1):105-15. doi: 10.1586/ers.12.1. Review.

PMID:
22283583
17.

Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study.

Cui Q, Robinson L, Elston D, Smaill F, Cohen J, Quan C, McFarland N, Thabane L, McIvor A, Zeidler J, Smieja M.

AIDS Patient Care STDS. 2012 Jan;26(1):12-9. doi: 10.1089/apc.2011.0199. Epub 2011 Oct 18.

18.

Evaluation outcomes resulting from an internet-based continuing professional development (CPD) asthma program: its impact on participants' knowledge and satisfaction.

Fleet LJ, Fox G, Kirby F, Whitton C, McIvor A.

J Asthma. 2011 May;48(4):400-4. doi: 10.3109/02770903.2011.563811.

PMID:
21504352
19.

Inhaler blues?

McIvor AR.

CMAJ. 2011 Mar 8;183(4):464. doi: 10.1503/cmaj.111-2025. No abstract available.

20.

The Christmas season as a risk factor for chronic obstructive pulmonary disease exacerbations.

Johnston NW, McIvor A, Lambert K, Greene JM, Hussack P, Gerhardsson de Verdier M, Higenbottam T, Lewis J, Newbold P, Herath A, Jenkins M.

Can Respir J. 2010 Nov-Dec;17(6):275-81.

21.

Evaluation of a novel method to assess corticosteroid responsiveness in chronic obstructive pulmonary disease.

Al-Ghimlas FA, McIvor A.

Ann Thorac Med. 2010 Oct;5(4):232-7. doi: 10.4103/1817-1737.69114.

22.

The impact of conservation on the status of the world's vertebrates.

Hoffmann M, Hilton-Taylor C, Angulo A, Böhm M, Brooks TM, Butchart SH, Carpenter KE, Chanson J, Collen B, Cox NA, Darwall WR, Dulvy NK, Harrison LR, Katariya V, Pollock CM, Quader S, Richman NI, Rodrigues AS, Tognelli MF, Vié JC, Aguiar JM, Allen DJ, Allen GR, Amori G, Ananjeva NB, Andreone F, Andrew P, Aquino Ortiz AL, Baillie JE, Baldi R, Bell BD, Biju SD, Bird JP, Black-Decima P, Blanc JJ, Bolaños F, Bolivar-G W, Burfield IJ, Burton JA, Capper DR, Castro F, Catullo G, Cavanagh RD, Channing A, Chao NL, Chenery AM, Chiozza F, Clausnitzer V, Collar NJ, Collett LC, Collette BB, Cortez Fernandez CF, Craig MT, Crosby MJ, Cumberlidge N, Cuttelod A, Derocher AE, Diesmos AC, Donaldson JS, Duckworth JW, Dutson G, Dutta SK, Emslie RH, Farjon A, Fowler S, Freyhof J, Garshelis DL, Gerlach J, Gower DJ, Grant TD, Hammerson GA, Harris RB, Heaney LR, Hedges SB, Hero JM, Hughes B, Hussain SA, Icochea M J, Inger RF, Ishii N, Iskandar DT, Jenkins RK, Kaneko Y, Kottelat M, Kovacs KM, Kuzmin SL, La Marca E, Lamoreux JF, Lau MW, Lavilla EO, Leus K, Lewison RL, Lichtenstein G, Livingstone SR, Lukoschek V, Mallon DP, McGowan PJ, McIvor A, Moehlman PD, Molur S, Muñoz Alonso A, Musick JA, Nowell K, Nussbaum RA, Olech W, Orlov NL, Papenfuss TJ, Parra-Olea G, Perrin WF, Polidoro BA, Pourkazemi M, Racey PA, Ragle JS, Ram M, Rathbun G, Reynolds RP, Rhodin AG, Richards SJ, Rodríguez LO, Ron SR, Rondinini C, Rylands AB, Sadovy de Mitcheson Y, Sanciangco JC, Sanders KL, Santos-Barrera G, Schipper J, Self-Sullivan C, Shi Y, Shoemaker A, Short FT, Sillero-Zubiri C, Silvano DL, Smith KG, Smith AT, Snoeks J, Stattersfield AJ, Symes AJ, Taber AB, Talukdar BK, Temple HJ, Timmins R, Tobias JA, Tsytsulina K, Tweddle D, Ubeda C, Valenti SV, van Dijk PP, Veiga LM, Veloso A, Wege DC, Wilkinson M, Williamson EA, Xie F, Young BE, Akçakaya HR, Bennun L, Blackburn TM, Boitani L, Dublin HT, da Fonseca GA, Gascon C, Lacher TE Jr, Mace GM, Mainka SA, McNeely JA, Mittermeier RA, Reid GM, Rodriguez JP, Rosenberg AA, Samways MJ, Smart J, Stein BA, Stuart SN.

Science. 2010 Dec 10;330(6010):1503-9. doi: 10.1126/science.1194442. Epub 2010 Oct 26.

23.

Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a cross-sectional study.

Cui Q, Carruthers S, McIvor A, Smaill F, Thabane L, Smieja M.

AIDS Res Ther. 2010 Mar 19;7:6. doi: 10.1186/1742-6405-7-6.

24.

Asthma that is unresponsive to usual care.

Chapman KR, McIvor A.

CMAJ. 2010 Jan 12;182(1):45-52. doi: 10.1503/cmaj.090089. Epub 2009 Oct 13. Review. No abstract available.

25.

Best practices for smoking cessation interventions in primary care.

McIvor A, Kayser J, Assaad JM, Brosky G, Demarest P, Desmarais P, Hampson C, Khara M, Pathammavong R, Weinberg R.

Can Respir J. 2009 Jul-Aug;16(4):129-34. Review.

26.

Asthma worsenings: approaches to prevention and management from the Asthma Worsenings Working Group.

Balter M, Ernst P, Watson W, Kim H, Cicutto L, Beauchesne MF, Cave AJ, Kaplan A, Hogg D, McIvor A, Smiley T, Rouleau M, FitzGerald JM; Asthma Worsenings Working Group.

Can Respir J. 2008 Nov-Dec;15 Suppl B:1B-19B.

28.
29.

The Brussels Declaration: the need for change in asthma management.

Holgate S, Bisgaard H, Bjermer L, Haahtela T, Haughney J, Horne R, McIvor A, Palkonen S, Price DB, Thomas M, Valovirta E, Wahn U.

Eur Respir J. 2008 Dec;32(6):1433-42. doi: 10.1183/09031936.00053108.

30.

[Chronic obstructive lung disease].

McIvor A, Little P.

Praxis (Bern 1994). 2008 Nov 19;97(23):1247-8. doi: 10.1024/1661-8157.97.23.1247. German. No abstract available.

PMID:
19016424
31.

Coccidioides immitis: two cases of misidentified mycosis.

Lee CH, Wilcox L, Chorneyko K, McIvor A.

Can Respir J. 2008 Oct;15(7):377-9.

32.

Canadian Adult Asthma Update 2008 key messages: a focus on translating knowledge into action in primary care.

McIvor A, Hodder R.

Can Respir J. 2008 Apr;15(3):121-2. No abstract available.

33.
34.

Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.

Calverley PM, Sanchez-Toril F, McIvor A, Teichmann P, Bredenbroeker D, Fabbri LM.

Am J Respir Crit Care Med. 2007 Jul 15;176(2):154-61. Epub 2007 Apr 26.

PMID:
17463412
35.

Chronic obstructive pulmonary disease.

McIvor A, Little P.

BMJ. 2007 Apr 14;334(7597):798. Review. No abstract available.

36.

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19.

PMID:
17310045
37.

Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids.

Ernst P, McIvor A, Ducharme FM, Boulet LP, FitzGerald M, Chapman KR, Bai T; Canadian Asthma Guideline Group.

Ann Intern Med. 2006 Nov 7;145(9):692-4. Review.

PMID:
17088583
38.

Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD.

Boulet LP, Becker A, Bowie D, Hernandez P, McIvor A, Rouleau M, Bourbeau J, Graham ID, Logan J, Légaré F, Ward TF, Cowie RL, Drouin D, Harris SB, Tamblyn R, Ernst P, Tan WC, Partridge MR, Godard P, Herrerias CT, Wilson JW, Stirling L, Rozitis EB, Garvey N, Lougheed D, Labrecque M, Rea R, Holroyde MC, Fagnan D, Dorval E, Pogany L, Kaplan A, Cicutto L, Allen ML, Moraca S, FitzGerald JM, Borduas F.

Can Respir J. 2006 Mar;13 Suppl A:5-47.

39.

The Canadian Optimal Therapy of COPD Trial: design, organization and patient recruitment.

Aaron SD, Vandemheen K, Fergusson D, Fitzgerald M, Maltais F, Bourbeau J, Goldstein R, McIvor A, Balter M, O'donnell D.

Can Respir J. 2004 Nov-Dec;11(8):581-5.

40.

Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.

Zervos M, Mandell LA, Vrooman PS, Andrews CP, McIvor A, Abdulla RH, de Caprariis PJ, Knirsch CA, Amsden GW, Niederman MS, Lode H.

Treat Respir Med. 2004;3(5):329-36.

PMID:
15606222
42.

State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease.

O'Donnell DE, Aaron S, Bourbeau J, Hernandez P, Marciniuk D, Balter M, Ford G, Gervais A, Goldstein R, Hodder R, Maltais F, Road J, McKay V, Schenkel J, Ariel A, Day A, Lacasse Y, Levy R, Lien D, Miller J, Rocker G, Sinuff T, Stewart P, Voduc N, Abboud R, Ariel A, Becklake M, Borycki E, Brooks D, Bryan S, Calcutt L, Chapman K, Choudry N, Couet A, Coyle S, Craig A, Crawford I, Dean M, Grossman R, Haffner J, Heyland D, Hogg D, Holroyde M, Kaplan A, Kayser J, Lein D, Lowry J, McDonald L, MacFarlane A, McIvor A, Rea J, Reid D, Rouleau M, Samis L, Sin D, Vandemheen K, Wedzicha JA, Weiss K; Canadian Thoracic Society.

Can Respir J. 2004 Jul-Aug;11 Suppl B:7B-59B.

43.

Asbestos in Scotland.

Gorman T, Johnston R, McIvor A, Watterson A.

Int J Occup Environ Health. 2004 Apr-Jun;10(2):183-92. Review.

PMID:
15281377
44.

Exclusion spirometry: a bad idea.

McIvor A.

Can Respir J. 2004 Apr;11(3):186-7. English, French. No abstract available.

45.

Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study.

FitzGerald JM, Sears MR, Boulet LP, Becker AB, McIvor AR, Ernst P, Smiljanic-Georgijev NM, Lee JS; Canadian Investigators.

Can Respir J. 2003 Nov-Dec;10(8):427-34.

46.

Inhaled corticosteroids should not be prescribed to all chronic obstructive pulmonary disease patients.

Bourbeau J, McIvor A.

Can Respir J. 2003 Apr;10(3):148-9. No abstract available.

47.

Voices from the pits: health and safety in Scottish coal mining since 1945.

McIvor A, Johnston R.

Scott Econ Soc Hist. 2002;22(2):111-33. No abstract available.

PMID:
19489173
48.

Implementing continuing education strategies for family physicians to enhance asthma patients' quality of life.

Blackstien-Hirsch P, Anderson G, Cicutto L, McIvor A, Norton P.

J Asthma. 2000 May;37(3):247-57.

PMID:
10831149
49.

Case report: allergic bronchopulmonary aspergillosis in asthma.

D'Urzo AD, McIvor AR.

Can Fam Physician. 2000 Apr;46:882-4. No abstract available.

50.

Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.

Langan CE, Zuck P, Vogel F, McIvor A, Peirzchala W, Smakal M, Staley H, Marr C.

J Antimicrob Chemother. 1999 Oct;44(4):515-23.

PMID:
10588313

Supplemental Content

Loading ...
Support Center